Nardil Section 19A

NARDIL (phenelzine sulfate) 15mg tablets are in short supply and the Therapeutic Goods Administration has approved supply of NARDIL phenelzine 15mg tablets USP, registered and marketed in Canada.

The Section 19A approval of this Canadian product, which is not registered in Australia, is in place until 31 Oct this year.

Pharmacists are asked to provide a copy of the Dear Patient Letter and the Australian CMI available at ebs. tga.gov.au when dispensing Canadian NARDIL 15 mg tablets.